Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Wall Street
Price Targets
CRNX Price Targets Summary
Crinetics Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
CRNX
is 59.08 USD
with a low forecast of 40.4 USD and a high forecast of 84 USD.
CRNX Last Price Targets
Crinetics Pharmaceuticals Inc
The latest public price target was made on Mar 20, 2024 by
Jonathan Wolleben
from
JMP Securities
,
who expects
CRNX
stock to
rise by 90%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Jonathan Wolleben
JMP Securities
|
80
USD
Upside 90% |
1 month ago
Mar 20, 2024
|
Crinetics (CRNX) PT Raised to $80 at JMP Securities, 'Paltusotine is Faster, Better, and More Convenient'
StreetInsider
|
Leland Gershell
Oppenheimer
|
54
USD
Upside 28% |
1 month ago
Mar 13, 2024
|
Crinetics (CRNX) PT Raised to $54 at Oppenheimer
StreetInsider
|
|
Leland Gershell
Oppenheimer
|
40
USD
Downside 5% |
7 months ago
Aug 31, 2023
|
Biotech Stock Crinetics Pharmaceuticals Positioned For Success In Chronic Endocrine Disorder Treatment, Says Analyst
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRNX's stock price target?
Price Target
59.08
USD
According to Wall Street analysts, the average 1-year price target for
CRNX
is 59.08 USD
with a low forecast of 40.4 USD and a high forecast of 84 USD.
What is Crinetics Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
181%
For the last 6 years the
compound annual growth rate for
Crinetics Pharmaceuticals Inc's revenue is
12%.
The projected
CAGR
for the next 3 years is
181%.
You don't have any saved screeners yet
